Form 4/A for KYNB KYNTRA BIO, INC.
Accepted 2026-05-19 15:08:15 ET · period of report 2026-05-14 · accession 0001815638-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-05-19 15:08 | 2026-05-14 | KYNB | Wettig Thane | CEO, Dir | P - Purchase | $7.09 | +2,800 | 27.2K | +11% | +$19.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-14 | P | A | 2,800 | $7.09 | 27,203 | D | — | — |